NVIDIA Corporation (NVDC34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 21.94 |
|---|---|
| 52-week range | 17.99 – 25.88 |
| Return, 1 month / 3 months | −9.7% / −1.2% |
| Return, 1 year / 3 years | +7.3% / +388.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 34.6% |
| Worst drawdown (1 year) | -22.0% |
| Average daily value traded | 112.88M BRL |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NVIDIA Corporation designs and supplies graphics processing units and related hardware and software. Its chips power gaming graphics cards, professional workstations and data centre systems used for artificial intelligence and accelerated computing. The company also provides networking products and software platforms for developers and enterprises. It is based in Santa Clara, California, and its products are used by gamers, researchers, designers and large computing operators around the world.
NVIDIA Corporation is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code NVDC34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NVIDIA Corporation (NVDC34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 21.94 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 292 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.3% and over the last three months it fell 1.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -13.9% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.2% | ||
| 6-month return | 6.1% | ||
| 12-month return, skipping the last month | 18.9% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.0% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 112.88M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −9.7% |
| 3 months | −1.2% |
| 6 months | +6.1% |
| 1 year | +7.3% |
| 3 years | +388.3% |
| 5 years | +725.8% |
Signals
| 50-day / 200-day average | 23.72 / 21.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | USD 0.0182 |
| 9 Mar 2026 | USD 0.0007 |
| 2 Dec 2025 | USD 0.0008 |
| 9 Sep 2025 | USD 0.0008 |
| 9 Jun 2025 | USD 0.0008 |
| 10 Mar 2025 | USD 0.0008 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.